| {"0": "Proteasome degradation", "1": "Alzheimers disease and mirna effects", "2": "Sphingolipid metabolism in senescence", "3": "Alzheimers disease", "4": "Retinoblastoma gene in cancer", "5": "Metapathway biotransformation phase i and ii", "6": "Sphingolipid metabolism overview", "7": "Sphingolipid metabolism integrated pathway", "8": "Sphingolipid pathway", "9": "G1 to s cell cycle control", "10": "Cholesterol metabolism with bloch and kandutschrussell pathways", "11": "Adipogenesis", "12": "Translation factors", "13": "Sterol regulatory elementbinding proteins srebp signaling", "14": "Cell cycle", "15": "Myometrial relaxation and contraction pathways", "16": "Nsp1 from sarscov2 inhibits translation initiation in the host cell", "17": "Dna mismatch repair", "18": "Dna replication", "19": "Pathogenic escherichia coli infection", "20": "Spinal cord injury", "21": "Dna irdamage and cellular response via atr", "22": "Ebola virus infection in host", "23": "Measles virus infection", "24": "Ciliary landscape", "25": "Il3 signaling pathway", "26": "Hepatitis b infection", "27": "Interleukin11 signaling pathway", "28": "Acute viral myocarditis", "29": "Nonalcoholic fatty liver disease", "30": "Pi3kakt signaling pathway", "31": "Aryl hydrocarbon receptor pathway wp2586", "32": "Embryonic stem cell pluripotency pathways", "33": "Mirna regulation of dna damage response", "34": "Thyroid stimulating hormone tsh signaling pathway", "35": "Hepatocyte growth factor receptor signaling", "36": "Fgfr3 signaling in chondrocyte proliferation and terminal differentiation", "37": "Osteoblast differentiation and related diseases", "38": "Parkinubiquitin proteasomal system pathway", "39": "Egfr tyrosine kinase inhibitor resistance", "40": "4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression", "41": "Purine metabolism", "42": "Dna repair pathways full network", "43": "Mecp2 and associated rett syndrome"} |